PL387584A1 - Zastosowanie kwasu kynureninowego i jego pochodnych w zapobieganiu lub leczeniu chorób trzustki - Google Patents

Zastosowanie kwasu kynureninowego i jego pochodnych w zapobieganiu lub leczeniu chorób trzustki

Info

Publication number: PL387584A1
Authority: PL; Poland
Prior art keywords: derivatives; preventing; treatment; application; kynurenic acid
Prior art date: 2009-03-23

Application number

PL387584A

Other languages

English (en)

Other versions

PL228037B1 (pl

Inventor

Andrzej Marciniak

Waldemar Andrzej Turski

Original Assignee

Andrzej Marciniak

Waldemar Andrzej Turski

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-03-23

Filing date

2009-03-23

Publication date

2010-09-27

2009-03-23 Application filed by Andrzej Marciniak, Waldemar Andrzej Turski filed Critical Andrzej Marciniak

2009-03-23 Priority to PL387584A priority Critical patent/PL228037B1/pl

2010-03-23 Priority to US13/258,654 priority patent/US20120029015A1/en

2010-03-23 Priority to PCT/PL2010/050012 priority patent/WO2010110689A1/en

2010-09-27 Publication of PL387584A1 publication Critical patent/PL387584A1/pl

2018-02-28 Publication of PL228037B1 publication Critical patent/PL228037B1/pl

Links

HCZHHEIFKROPDY-UHFFFAOYSA-N kynurenic acid Chemical compound C1=CC=C2NC(C(=O)O)=CC(=O)C2=C1 HCZHHEIFKROPDY-UHFFFAOYSA-N 0.000 title 2
208000024691 pancreas disease Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL387584A 2009-03-23 2009-03-23 Zastosowanie kwasu kynureninowego w zapobieganiu lub leczeniu chorób trzustki PL228037B1 (pl)

Priority Applications (3)

Application Number	Priority Date	Filing Date	Title
PL387584A PL228037B1 (pl)	2009-03-23	2009-03-23	Zastosowanie kwasu kynureninowego w zapobieganiu lub leczeniu chorób trzustki
US13/258,654 US20120029015A1 (en)	2009-03-23	2010-03-23	Novel medical use of kynurenic acid, its precursors and derivatives
PCT/PL2010/050012 WO2010110689A1 (en)	2009-03-23	2010-03-23	A novel medical use of kynurenic acid, its precursors and derivatives

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PL387584A PL228037B1 (pl)	2009-03-23	2009-03-23	Zastosowanie kwasu kynureninowego w zapobieganiu lub leczeniu chorób trzustki

Publications (2)

Publication Number	Publication Date
PL387584A1 true PL387584A1 (pl)	2010-09-27
PL228037B1 PL228037B1 (pl)	2018-02-28

Family

ID=42335243

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL387584A PL228037B1 (pl)	2009-03-23	2009-03-23	Zastosowanie kwasu kynureninowego w zapobieganiu lub leczeniu chorób trzustki

Country Status (3)

Country	Link
US (1)	US20120029015A1 (pl)
PL (1)	PL228037B1 (pl)
WO (1)	WO2010110689A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN112168822B (zh) *	2020-09-27	2022-11-08	集美大学	犬尿酸在改善高脂饮食致血脂异常、肥胖、肠道菌群混乱中的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0442878A4 (en) *	1988-04-05	1991-10-23	Abbott Laboratories	Derivatives of tryptophan as cck antagonists
FR2849598B1 (fr) *	2003-01-07	2006-09-22	Merck Sante Sas	Utilisation d'inhibiteurs de la kynurenine-3-hydroxylase pour le traitement du diabete, par augmentation du nombre de cellules des ilots de langerhans
WO2005059546A2 (en) *	2003-12-12	2005-06-30	Bayer Healthcare Ag	Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 35 (gpr35)
FR2864535B1 (fr) *	2003-12-24	2006-12-22	Merck Sante Sas	Derives acides de quinoline et leurs applications en therapeutique
CA2619706A1 (en) *	2005-08-17	2007-02-22	Schering Corporation	Novel high affinity quinoline-based kinase ligands
DE102005053947A1 (de) *	2005-11-11	2007-05-16	Univ Ernst Moritz Arndt	Neue Arzneimittel
HUP0700051A2 (en) *	2007-01-17	2008-09-29	Univ Szegedi	Use of kynurenic acid and derivatives there of for treating of gastrointestinal disorders associated with enhanced motility and inflammation

2009
- 2009-03-23 PL PL387584A patent/PL228037B1/pl unknown
2010
- 2010-03-23 US US13/258,654 patent/US20120029015A1/en not_active Abandoned
- 2010-03-23 WO PCT/PL2010/050012 patent/WO2010110689A1/en not_active Ceased

Also Published As

Publication number	Publication date
US20120029015A1 (en)	2012-02-02
PL228037B1 (pl)	2018-02-28
WO2010110689A1 (en)	2010-09-30

Similar Documents

Publication	Publication Date	Title
PH12013500892A1 (en)	2013-07-01	Composition for use in the prevention and/or treatment of skin conditions and skin diseases
EP2451503A4 (en)	2014-02-19	EYE IMPLANTS AND METHOD FOR THE RELEASE OF EYE IMPLANTS IN THE EYE
GB2503861B (en)	2014-03-19	Enzyme delivery systems and methods of preparations and use
IL221874A (en)	2016-09-29	History of pyrimidine and their use in the treatment of respiratory diseases such as copd
EP2437743A4 (en)	2012-11-28	OPHTHALMIC FORMULATIONS OF FLUTICASONE AND METHODS OF USE
GB201302652D0 (en)	2013-04-03	Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
ZA200905101B (en)	2012-01-25	Diagosis and treatment of preeclampsia
ZA201106299B (en)	2014-01-29	Composition comprising caftaric acid and/or derivatives thereof
GB2496794B (en)	2017-11-01	Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
IL236830A0 (en)	2015-03-31	Diazahomoredene derivatives and methods of using them
HRP20150052T1 (xx)	2015-03-27	Fungicidni pripravak i postupak za suzbijanje bolesti biljaka
SG10201507199UA (en)	2015-10-29	Use of lysosomal acid lipase for treating lysosomal acid lipase deficiency in patients
BRPI1010517A2 (pt)	2017-01-31	métodos para prevenção e/ou tratamento de doenças de armazenamento lisossomal
ZA201200608B (en)	2014-06-25	L-serine to be used as a drug for preventing and/or treating an inflammatory response of the skin
ZA201106300B (en)	2013-02-27	Composition comprising chicoric acid and/or derivatives thereof
IL219934A0 (en)	2012-07-31	Quinazolin-4(3a)-one derivatives and methods of use thereof
ZA201202892B (en)	2014-10-29	Ophthalmic formulation and method of manufacture thereof
PL387584A1 (pl)	2010-09-27	Zastosowanie kwasu kynureninowego i jego pochodnych w zapobieganiu lub leczeniu chorób trzustki
EP2480099A4 (en)	2015-05-27	COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING METABOLIC DISEASES
HRP20151393T8 (hr)	2016-07-01	UPORABA BENZIDAMINA U LIJEČENJU BOLESTI KOJE SU p40-OVISNE
ZA201104722B (en)	2012-12-27	Animal treatment formulation and methods of use
IL208231A0 (en)	2010-12-30	Agent for preventing and/or treating vascular diseases
GB0905973D0 (en)	2009-05-20	Detection and/or treatment of diseases associated with autoantibodies
IL222642A0 (en)	2012-12-31	Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males
WO2010149658A3 (en)	2011-03-31	Pharmaceutical composition comprising gamma - butyrobetaine and meldonium